Keryx Biopharma Appoints Scott Holmes As CFO

(RTTNews) - Keryx Biopharmaceuticals, Inc. (KERX) said Monday that it has appointed Scott Holmes as Chief Financial Officer, effective immediately.

Holmes will succeed James Oliviero whose planned departure was announced earlier this year. Oliviero will stay with the company through a transition period.

Holmes joins Keryx from AMAG Pharmaceuticals where he most recently served as senior vice president, finance and investor relations. Prior to AMAG, from 2009 to 2011, he was vice president of finance and treasurer of Molecular Biometrics Inc., and vice president of finance & administration of On-Q-ity Inc. Prior to 2009, he spent five years at Dynogen Pharmaceuticals, Inc., a privately held pharmaceutical company, where he was vice president finance & administration and treasurer. Earlier in his career, Holmes served as the controller at Keryx Biopharmaceuticals and was a senior auditor with Ernst & Young, LLP.